<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110920">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01868165</url>
  </required_header>
  <id_info>
    <org_study_id>P40221</org_study_id>
    <nct_id>NCT01868165</nct_id>
  </id_info>
  <brief_title>Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)</brief_title>
  <official_title>Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <authority>United Kingdom: National Health Service</authority>
    <authority>United Kingdom: National Institute for Health Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older adults are at increased risk of high blood pressure and cognitive decline. High blood
      pressure itself also increases risk of cognitive decline. A particular type of blood
      pressure lowering drug (a calcium channel blocker(CCB)) may lower risk of dementia in
      younger adults but there is no clear evidence of it's impact in those &gt;=80. It is important
      that we know whether CCB use impacts on cognitive function in this age group. This study
      will compare change in cognitive function in those taking CCBs to those not taking CCBs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is an observational cohort study examining cognitive change in those participants
      taking antihypertensives and aged 80 and over and comparing cognitive change in those taking
      calcium channel blockers with those taking other types of antihypertensive medication.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in cognitive function</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Cognitive Ability, General</condition>
  <condition>High Blood Pressure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        UK Primary care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Aged 80 and over Receiving pharmacological treatment for hypertension Mini Mental State
        Exam score &gt;24 No other condition likely to limit life to less than one year or to prevent
        the taking of informed consent.

        Exclusion Criteria:

        Aged under 80 years Not receiving pharmacological treatment for hypertension Mini Mental
        State Exam score &lt;25 Diagnosed with a condition likely to limit life to less than one year
        or to prevent the taking of informed consent.

        Presence of a sensory impairment or an existing neuropsychological deficit of sufficient
        severity to prevent cognitive testing.

        Presence of a condition that will prevent cognitive testing, registered blind, profoundly
        deaf, suffering from an aphasia.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>80 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruth Peters, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London, UK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruth Peters, PhD</last_name>
    <phone>442075948974</phone>
    <email>r.peters@imperial.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Kiltearn Medical Centre</name>
      <address>
        <city>Nantwich</city>
        <state>Cheshire</state>
        <zip>CW5 5NX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carolyn Paul, MBChB, MRCGP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ashfields Primary Care Centre</name>
      <address>
        <city>Sandbach</city>
        <state>Cheshire</state>
        <zip>CW11 BEQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Neil Paul, MCChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Whitby Group Practice</name>
      <address>
        <city>Whitby</city>
        <state>North Yorkshire</state>
        <zip>YO21 1SD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Terry McCormack, MBBS, GPCCT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Axholme Practice</name>
      <address>
        <city>Epworth</city>
        <state>Yorkshire</state>
        <zip>DN9 1EP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Richard Falk, MBChB, MRCGP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr Moss and Partners</name>
      <address>
        <city>Harrogate</city>
        <zip>HG1 5JP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nick Taylor, MBBS</last_name>
    </contact>
    <investigator>
      <last_name>Nick Taylor, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gale Farm Surgery</name>
      <address>
        <city>York</city>
        <zip>YO24 3BU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicki Law, MBChB</last_name>
    </contact>
    <investigator>
      <last_name>Nicki Law, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haxby Group Practice</name>
      <address>
        <city>York</city>
        <zip>YO32 2LL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William Laughey, MBChB</last_name>
    </contact>
    <investigator>
      <last_name>William Laughey, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>May 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cognitive decline</keyword>
  <keyword>High blood pressure</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Ageing</keyword>
  <keyword>Dementia</keyword>
  <keyword>Antihypertensives</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calcium Channel Blockers</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
